Pipeline | Ensol Biosciences Inc.

New Drug Pipeline
Technology
- KISDD 3.0
- ETONS 2.0
IR/PR
About Ensol
KO

New Drug Pipeline
Technology
- KISDD 3.0
- ETONS 2.0
IR/PR
About Ensol
KO

New Drug Pipeline

New Drug Pipeline

Pipeline

Musculoskeletal Disease
- Degenerative Disc Disease Drug(P2K)
- Osteoarthritis(E1K)
Oncology
- Cancer(C1K)
Central Nervous System
- Alzheimer’s Disease Drug(M1K)
Metabolic Disease
- Obesity(H1K)
Skin Disease
- Atopic dermatitis(A1K)
Animal Drugs
- Animal Osteoarthritis Drug(EAD100)

New Drug Pipeline

Pipeline

Pipeline

Musculoskeletal Disease

Oncology

Central Nervous System

Metabolic Disease

Skin Disease

Animal Drugs

pipe_table

회사로고

Ensol Biosciences Inc. | CEO : Hae-Jin Kim | Business Number : 314-81-39908
Headquarter : 51, Techno 10-ro, Yuseong-gu, Daejeon, 34036, Korea | TEL : +82-42-939-4500 | FAX : +82-42-939-4501
Copyright (c) 2019 Ensol Biosciences Inc. All Rights Reserved.